Objective: To correlate changes in vestibular pain thresholds to general pain thresholds in a subgroup of women with provoked vestibulodynia taking part in a treatment study.
W omen with provoked vestibulodynia, also known as vulvar vestibulitis syndrome, suffer from superficial dyspareunia. 1 It is a common disorder in mainly young women, with an estimated prevalence of 12% to 13%. 2, 3 The pain is usually provoked by intercourse, tampon use, or sometimes by tight clothing and cycling. During clinical examination, the women present a hypersensitivity of the vestibular mucosa where a light touch or pressure gives rise to a burning pain sensation. The etiology is considered multifactorial including both physical and psychosexual causes. 4 Provoked vestibulodynia is currently classified and treated as a localized pain disorder. 1, 4, 5 The pain mechanisms involved, however, are only partly investigated. Earlier studies have shown an increased innervation and lowered pain thresholds in the vestibular mucosa of patients as compared with nonaffected women. [6] [7] [8] [9] [10] These findings are compatible with an ongoing peripheral sensitization of the vestibular sensory nerves. Other studies have shown that women with provoked vestibulodynia also have lower pain thresholds to various stimuli in other body locations than the vestibule. 9, 11 In addition, they more often report bodily pain as compared with healthy women of the same age. 12 The results of these studies indicate that women with vestibulodynia have a possible alteration of central pain modulation.
We have previously conducted a prospective treatment study for women with provoked vestibulodynia. In that study, patients were randomized to either topical lidocaine or electromyographic (EMG) biofeedback treatment for 4 months. 13 Outcome measures were vestibular pain thresholds, sexual functioning, psychosocial adjustments, and quality of life analyzed before treatment and at 12 months after the treatments were completed. Both treatments showed significantly improved values for the outcome measures and no differences between the treatments were observed. 13 The aim of the present study was to correlate changes in vestibular pain thresholds to general pain thresholds in a subgroup of women taking part in the treatment study. Subjective improvement and changes in physical and mental health as well as general bodily pain were also analyzed.
MATERIALS
The study was performed at the vulvar clinics at Sundsvall Hospital in northern Sweden and Danderyd Hospital in Stockholm. Thirty-five women with provoked pain around the vaginal opening and who had completed treatment and a 6-month follow-up were included in the study. Eighteen women had been randomized to treatment with topically applied lidocaine (2% gel or 5% ointment) on the vestibule 5 times per day for 4 months. Another 17 women were randomized to surface EMG biofeedback, using a portable instrument for 10 minutes' practice twice a day for 4 months according to a standard protocol. 13 Because no differences in outcome measures for the 2 treatments were observed, all 35 women were included as patients in the present study. Inclusion criteria for patients were provoked introital pain, moderate to pronounced pain during most intercourse attempts, duration of symptoms Z6 months and age Z18 years. Exclusion criteria for patients were severe medical, psychiatric or psychologic disorders, and pregnancy.
Thirty healthy women of the same age as the patients served as a reference group for general pain thresholds and physical and mental health (Short Form-36). Half of the control women were using combined oral contraceptives and the other half was using nonhormonal contraceptive methods. The control women were mainly recruited among university students. Exclusion criteria for the control group were medical, psychiatric or psychologic disorders, dyspareunia, pregnancy, ongoing medication with antidepressives and/or analgesics, and age <18 years.
The study was approved by the Local Ethics Committees. The women gave their informed and written consent.
METHODS
Pain measurements, analyses of physical and mental health using Short Form-36 (SF-36), and experienced bodily pain were carried out twice for the patients, before treatment started and at 6 months after the treatment was completed. Subjective treatment outcome was evaluated in the patients at the 6-month follow-up. For the group of healthy controls, general pain measurements, and filling out SF-36 were done once. In addition, all participants filled out a socio-medical questionnaire at their first visit.
Pain Threshold Assessments
Pressure pain thresholds (PPTs) in the vestibule were measured by a vulvalgesiometer, manufactured by Pukall et al. 14 This is a simple mechanical instrument consisting of a set of cylindrical devices that contains springs of varying compression rates. The set exerts a wide range of forces calibrated from 3 to 1000 g. At the bottom of each device, a cotton-swab tip is fitted. PPTs were measured in 2 separate areas of the vestibular mucosa, the anterior part of the vestibule (area A) and the posterior part (area B), by slowly applying higher force levels until pain was reported, Figure 1 . At this point, participants rated pain intensity on a visual analog scale (VAS) 0 to 100, with 0 representing no pain and 100 the most intense pain imaginable. In the introduction study of the algesiometer, normative values for vestibular pain thresholds are given as mean 286 g ( ± SEM 86) for healthy women with a mean age of 25.7 years. 14 Because normative values for vestibular pain thresholds exist for women in the same age group as ours, pain assessments in the vestibule were not carried out for healthy controls in the present study.
General pain thresholds on the upper arm and leg were determined by a pressure algometer (Somedic Sales AB Ho¨rby, Sweden). 15 The algometer was held perpendicularly to the tissue surface and the induced pressure was between 0 and 2000 kPa, increased by a velocity of 75 to 100 kPa/s. Two different areas were tested. First, the lower leg was tested on the anterior tibial muscle, approximately 5 cm below and 3 cm lateral of tuberositas tibiae. Thereafter PPT of the upper arm was tested on the deltoid muscle, 3 cm proximal to the tendon insertion on the humerus. Following introduction to the method and a training session, the women were asked to define when the nonpainful pressure changed into a painful sensation by pressing a button, whereby the pressure value was captured on a digital display. At this point, pain intensity was defined using VAS 0 to 100. All pain measurements in both patients and healthy controls were carried out on days 5 to 13 of the menstrual cycle to control for any differences in pain perception during that time. 16 SF-36 is widely used, has a high validity and reliability, and a study using the Swedish version supports the cross-cultural stability of the ratings. 17, 18 Subjective Outcome and Bodily Pain
SF-36
The women with provoked vestibulodynia were asked at the 6-month follow-up to estimate their overall response to the obtained treatment (worse, no change, improved, or completely cured). Before treatment and at the 6-month follow-up, pain from the gastrointestinal tract, neck, shoulders, back, and joints were estimated and scored as never, sometimes, frequently, or very frequently.
STATISTICS
Wilcoxon matched pairs test was used for analyses of vestibular and general pain thresholds and corresponding VAS values before and after treatment in the patients. T test and Mann-Whitney U test were used for analyzing data concerning characteristics of patients and controls, general pain thresholds, and corresponding VAS values in patients compared with controls. The Tukey-Kramer test was used for analyzing differences in SF-36 between patients and controls. Chi-square test was used to analyze differences in subjective outcome and bodily pain. Differences in vestibular and general pain thresholds between patients who were cured, improved, or unimproved were analyzed by Kruskal-Wallis analysis of variance with multiple comparisons. The significant level of P<0.05 was used for all statistical tests.
RESULTS
The mean age of the patients was 25.1 years (range: 19 to 36), with 23.6 years (range: 18 to 33) for the group of healthy controls (ns). The patients had had vestibulodynia symptoms for a median time of 36 months and the median time since last intercourse was 2.4 months, as compared with 0.25 months for the healthy controls, P<0.001. Vestibulodynia cases used oral contraceptives (26%) in a lower frequency than healthy controls (50%), P<0.05. Further data on characteristics of patients and controls are shown in Table 1 .
Vestibular Pain Thresholds
For women with vestibulodynia, PPTs in the vestibular area A increased from 30 g (20 to 50) [median value and interquartile range (IQR)] before treatment to 70 g (50 to 80) at the 6-month follow-up, P<0.001, Figure 2 . In area B, the median PPT increased from 20 g (15 to 30) before treatment to 30 g (20 to 50) 6 months after treatment, P<0.001, Figure 2 . Lower PPTs were obtained in area B as compared with area A both before treatment (P<0.001) and at the 6-month follow-up (P<0.001), Figure 2 . Median VAS values in the vestibule varied from 38 to 46 in the patients. No differences in VAS were observed for areas A and B either before or at 6 months after treatment was completed.
General Pain Thresholds
The PPTs on the leg were lower for the patients before treatment, median 633 kPa [412 to 870 (IQR)] as compared with healthy controls, median 888 kPa (731 to 1188), P<0.01, Figure 3 . The patients also had lower PPTs on the leg 6 months after completed treatment, 730 kPa (468 to 887) as compared with the healthy controls, 888 kPa (731 to 1188), P<0.05, Figure 3 . For the patients, no significant increase in PPTs was observed at the 6-month follow-up as compared with before treatment. Similar results were obtained for PPTs on the arm. Before the treatment, the patients showed median value 362 kPa (204 to 561) compared with healthy controls, 684 kPa (525 to 915), P<0.001, Figure 4 . At the 6-month follow-up, the PPTs in the patients were 383 kPa (218 to 586) as compared with the controls, 684 kPa (525 to 915), P<0.001, Figure 4 . For the patients, no significant increase in PPTs was observed at the 6-month follow-up as compared with before treatment. In the patients, the PPTs on the arm were lower compared with the leg both before treatment (P<0.001) and 6 months after treatment (P<0.001). No differences in VAS values were observed on either leg or arm and the median values ranged from 29 to 33.
Subjective Outcome and Bodily Pain
Three patients (9%) reported total cure at the 6month follow-up, 25 patients (71%) were improved, and another 5 patients (14%) reported no change in dyspareunia. The subjective outcome is missing in 2 patients. The number of patients who frequently or very frequently reported pain from other body regions than the vestibule was reduced at the 6-month follow-up compared with before treatment. Fewer symptoms were reported from the gastrointestinal tract (P<0.01), shoulders (P<0.001), joints (P<0.01), and back (P<0.001).
Of the 28 women who reported they were cured or improved at the 6-month follow-up, 15 (54%) obtained higher PPTs in both vestibular areas A and B. Separate analyses of general pain thresholds were calculated for this group. No changes in PPTs and corresponding VAS values on the arm or leg were shown at the 6-month follow-up as compared with before the treatment. Analyses of general pain thresholds correlated to subjective outcome showed that the 3 patients who were cured had PPTs on the leg and arm both before the treatment and at the 6-month follow-up within the same range as the controls, Table 2A . In contrast, the 5 unimproved women seemed to have lower general pain thresholds compared with both controls and those who were cured. No obvious changes were observed for the vestibular pain thresholds between the subgroups, Table 2B .
SF-36
Comparisons between vestibulodynia patients and healthy controls showed differences for General Health and Vitality before treatment. This initial difference was restored at the 6-month follow-up. No differences were observed in the patients pretreatment and posttreatment, Table 3 .
DISCUSSION
The aim of this study was to correlate PPTs of the vestibule to general PPTs and subjective treatment outcome in women treated for provoked vestibulodynia. The results showed that treating the vestibulodynia by either topical lidocaine or EMG-biofeedback significantly increased the vestibular pain thresholds, reduced pain during intercourse, and improved bodily pain. The PPTs on the leg and arm were significantly lower both before and at the 6-month follow-up in patients as compared with controls. However, in this study, general PPTs did not seem to be affected by treating the superficial dyspareunia.
The major reported improvement of the dyspareunia is compatible with the potential pain-reducing mechanisms for both treatments received. EMG biofeedback has been reported to decrease pain during intercourse and resting tension as well as restore stability of the pelvic floor muscles after 16 weeks of practice in women with vestibulodynia. 19 The reestablishment of the muscle function with an improved capacity to relax the pelvic floor during sexual activity is thought to reduce the coital pain. For topical treatment with frequent application of lidocaine, the transmission in C-fibers is blocked, resulting in desensitization of peripheral nociceptors in the vestibular mucosa. 20 However, there is still a discrepancy in vestibular pain thresholds between our patients who consider themselves as being cured or improved and normative values of unaffected women. 14 None of the 3 women who reported total cure had vestibular pain thresholds above 100 g, whereas one improved women reached 200 g (extreme value) in area A after completing the treatment. The result implies that the vestibular mucosa still presents enhanced pain sensitivity when measured with objective methods even if a patient reports pain-free intercourse. The lack of concordance between vestibular pain thresholds and subjective outcome is an interesting finding which may have several explanations. Painful touch of the vestibule and painful dilation of the vaginal opening are diagnostic criteria for provoked vestibulodynia. 21 Vestibular pressure pain and subjective estimation of coital pain have been the most common methods evaluating the effect of various treatments for vestibulodynia. 19, 22, 23 In this study, vestibular pain thresholds were analyzed by pressure of a cotton-swab tip connected to a calibrated spring device. The tissue lateral of the hymenal ring was investigated and this part of the mucosa is stretched during vaginal penetration. It is not clear, however, whether pressure of this area best represents the origin of pain experienced during intercourse in these women and thus should be used for evaluation of objective treatment outcome. In a previous study analyzing pain thresholds for various stimuli in women with vestibulitis or provoked vestibulodynia, a small rubber balloon was used for distension of the vaginal introitus. 8 The balloon was gently filled with air and thus gradually expanded the vaginal opening until the pain threshold was reached. The result showed significant lower pain thresholds in the patients compared with healthy controls that mainly interrupted the distension due to discomfort or difficulties in keeping the balloon in place. 8 Different mechanosensitive nociceptors may be activated during the pressure-induced pain by the cotton-swab tip contrary to the stretch-induced pain during distension. Studies on experimental rectal pain have given little evidence that mural mechanoreceptors are activated by variations in pressure or volume but rather by deformation (strain) of the gastrointestinal wall. 24 In clinical practice, it is easier to use the cotton-swab test than the balloon, but the distension proceeding may be a better method for evaluation of vaginal penetrative pain and should be considered in future studies.
This discrepancy in vestibular pain thresholds and subjective outcome may also be explained by an altered cognitive processing of pain in women with vestibulodynia. Anxiety and fear of pain are known to play a central role in patients with chronic pain and have also been observed in women with long-standing vulvar pain. [25] [26] [27] In addition, hypervigilance for pain-relevant stimuli in vestibulodynia patients has been reported. A heightened awareness of pain may result in a distraction from sexual stimuli affecting the sexual arousal and exacerbate the pain experience during intercourse. 28 Although the (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) 50 20 (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) 25 (25) (26) (27) (28) (29) (30) Values are given as median and IQR. A1 = anterior vestibule before treatment and A2 at 6-month follow-up. B1 = posterior vestibule before treatment and B2 at 6-month follow-up. Scores are given in percentage of highest possible score for each item ± SEM *P<0.05 for the comparison between patients before treatment and healthy controls. No other differences were observed. received treatments were designed to act mainly locally in the genital area, a reduction of anxiety and fear of pain may also have been obtained. During the treatment, all patients were given regular care and support at visits and follow-ups. Most probably, many patients developed better pain-coping strategies during the treatment proceedings. A placebo effect may also account for some of the subjective improvements. However, the perception of pain at the threshold level seemed to be similar during the 2 measurements according to the VAS scores. Because no differences in VAS scores were observed, the patients' reports of when the stimulus became painful seem reliable and stable over time.
Lower general pain thresholds in women with vestibulodynia have previously been reported suggesting that a generalized systemic hypersensitivity may contribute to the condition. 9, 11, 29 One question is whether these women have an ongoing central sensitization due to repetitive peripheral stimuli of nociceptors or whether there is a genetic predisposition for pain sensitivity in general. In a recently published study by Tegeder et al, 30 a genetic predisposition for increased pain sensitivity was found. Individuals carrying a pain-protective haplo-type for guanosine-triphosphate cyclohydrolase were significantly less sensitive to mechanical pain and tended to be less sensitive to heat and ischemic pain. 30 The finding of frequent bodily pain in women with vestibulodynia 12,31 supports the hypothesis of an alteration of the systemic pain modulation. At the follow-up, a significant reduction in bodily pain was reported in the patients and the initial differences in the SF-36 items General Health and Vitality were restored. These findings may have clinical implications. If the peripheral sensory input from the vestibule is diminished, a reduction of central sensitization may be achieved. There were 10 months between the 2 testing proceedings and one may speculate as to whether the general pain thresholds would have increased with further observation time.
When the participants were divided according to subjective outcome and new analyses of general pain thresholds were performed, an interesting observation was found. The PPTs on both the leg and arm did not seem to differ between the subgroup of 3 women being cured and the healthy controls, neither before nor after the treatment. At the 6-month follow-up, the cured women also seemed to have higher PPTs as compared with the 5 women who did not benefit from the treatments. These results should be carefully interpreted because the number of participants is small omitting statistical calculations. Therefore, it is too early to conclude that a woman with general pain thresholds within normal range is more likely to benefit from treatment. Nevertheless, it would be valuable to further evaluate whether general pain threshold is a predictive factor for treatment outcome in women with vestibulodynia. It has been reported that patients with other localized pain disorders, for example, temporomandibular disorders and whiplash injury, also have lower generalized pan thresholds. 32, 33 A subgroup of patients with whiplash injury and low PPTs reported persisting moderate to severe symptoms 6 months after the injury. It was concluded that sensory hypersensitivity was associated with poor recovery. 33 The PPTs on the leg and arm were also lower in women with vestibulodynia compared with healthy women both before and after completed treatment. A tendency of increased pain thresholds, however, was observed at the 6-month follow-up. One explanation could be that the patients tolerated the induced pressure pain better the second time they were tested. At the 6month follow-up, they were familiar with the method and might have been mentally more prepared for the evoked pain sensation. Because the control participants were only tested at one occasion, comparisons between the 2 groups cannot be made. This illustrates some methodological problems in performing the study. It was difficult to recruit a control group that was willing to come back 10 months later for a second testing session. Valuable data concerning whether general pain thresholds change over time in the unaffected women is therefore missing, which is a limitation to the study. One may also speculate as to whether the observed tendency of increased general pain thresholds in the patients would have been significant at the follow-up if a larger number of participants had been included. The statistical power of the initial treatment study was calculated for the primary outcome of quality of life measurements.
In conclusion, EMG biofeedback and topical lidocaine treatment for women with provoked vestibulodynia increase vestibular pain thresholds, reduce dyspareunia, and improve bodily pain. The patients showed a general hypersensitivity to pressure pain. The cause of the enhanced pain hypersensitivity is still unclear, but factors such as genetic predisposition and central sensitization may play a role. In this study, general PPTs did not seem to be affected by treating the superficial dyspareunia but pain thresholds within normal range may be a predictive factor for successful treatment.
